Striatum

• The Impacts of Adolescent Cannabinoid Exposure on Striatal Anxiety- and Depressive-Like Pathophysiology Are Prevented by the Antioxidant N-Acetylcysteine (02 Sep 2024)
  
• Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome (02 Sep 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• Cannabinoid signaling and risk in Huntington's disease (25 Aug 2024)
  
• Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease (21 Aug 2024)
  
• Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease (20 Aug 2024)
  
• Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention (20 Aug 2024)
  
• Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (12 Aug 2024)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)